🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Asthma Atopic

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling) NCT02327897n/a1 site📍 Research Triangle Park National Institute of Environmental Health Sciences (NIEHS) Prospective Longitudinal Observational Research in Atopic Dermatitis NCT04240522n/a1 site📍 Zurich University of Zurich Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. NCT04898283Phase 327 sites📍 Valladolid📍 Tarancón📍 Alcalá de Henares Inmunotek S.L. · Tests: 10,000 MG01 +10,000 T521, 30,000 MG01 +10,000 T521, Placebo subcutaneous Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma NCT06960382Phase 1, Phase 21 site📍 Zurich University of Zurich · Tests: ALUTARD SQ® Felis domesticus Microbiome and Atopy in Mali NCT07051902n/a2 sites📍 Bamako📍 Bamako National Institute of Allergy and Infectious Diseases (NIAI… Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NCT07055542NA6 sites📍 Albury📍 Box Hill📍 Clayton University of Melbourne · Tests: Observational Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma NCT06317909NA1 site📍 Hanover Fraunhofer-Institute of Toxicology and Experimental Medicine · Tests: allergen challenge Viral Mucosal Reprogramming NCT05331170Phase 21 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: Research Grade RG-RV Short Treatment with Omalizumab for Severe Asthma NCT04763447Phase 41 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Attempt to withdrawal OMA treatment, Continuation of OMA treatment Deployment o the Multidisciplinary Prospective Cohort Imminent NCT04334031NA1 site📍 Lille University Hospital, Lille · Tests: Biobanking with genetic analysis, SF-12 questionnaire Nationwide Research on the Rewilding of Kindergarten Yards NCT06390878NA2 sites📍 Helsinki📍 Tampere Natural Resources Institute Finland · Tests: Biodiversity, Playground equipment Allergy and Immunology Natural History Study NCT05584488n/a1 site📍 New York Columbia University Innate Immunity in Allergic Asthma NCT06068335n/a1 site📍 Orlando University of Central Florida Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites NCT04435990Phase 332 sites📍 Santiago de Compostela📍 Elche📍 Torrevieja Inmunotek S.L. · Tests: 10,000 MM09, 30,000 MM09, Placebo subcutaneous Omalizumab Before Onset of Exacerbations NCT05332067Phase 21 site📍 Washington D.C. Children's National Research Institute · Tests: Omalizumab, Placebo Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma NCT05008965Phase 213 sites📍 Kaohsiung City📍 Kaohsiung City📍 New Taipei City Oneness Biotech Co., Ltd. · Tests: FB825, Placebo Restoration of Microbiota in Neonates NCT03928431NA1 site📍 Stockholm Karolinska Institutet · Tests: Maternal microbiota ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar NCT07425639n/a1 site📍 Montpellier Celltrion HealthCare France · Tests: Omalizumab Plant Stanol Esters and Preventing Asthma Symptoms NCT03983603NA1 site📍 Maastricht Maastricht University Medical Center · Tests: Soft chews containing 0.5g plant stanols (delivered as plant stanol esters), Placebo soft chew Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis NCT07313904n/a1 site📍 Ningbo First Affiliated Hospital of Ningbo University Expression of TSLP Isoforms in Asthma NCT07786870n/a1 site📍 Warsaw Medical University of Warsaw · Tests: No Intervention: Observational Cohort Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients NCT07342803Phase 21 site📍 Shanghai Longbio Pharma · Tests: LP-003 Injection, Omalizumab, Placebo Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen NCT04891237Phase 332 sites📍 Tarancón📍 Alcalá de Henares📍 Tres Cantos Inmunotek S.L. · Tests: 10,000 MG01 + 10,000 T517, 30,000 MG01 + 10,000 T517, Placebo Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df NCT07348302Phase 319 sites📍 Nueve de Julio📍 Rosario📍 Rosario Inmunotek S.L. · Tests: Allergen Immunotherapy Extract A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up NCT06732414n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy